Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...

Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.

Men with MS who started on high-efficacy DMTs had fewer relapses than those who started with moderate-efficacy DMTs, a U.S.

MS patients show large differences between vascular age and chronological age, even if they don't have cardiovascular disease ...

OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

Columnist Ahna Crum is taking on a new year with a different approach: meeting the day-to-day new beginnings in life with ...

Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...

Certain health issues seen in youth with MS in the five years before diagnosis confirm a prodromal period may exist in ...

Do your research. And don’t just trust the internet. Don’t just trust one doctor. Try to get a second opinion. When you’re first diagnosed, one of the most amazing things you can do for ...

Desiree Lama, who lives in Texas, was diagnosed with relapsing-remitting multiple sclerosis in 2016. She shares advice for patients building a treatment plan with an MS team they don’t yet trust.